OBALON THERAPEUTICS INC's ticker is OBLN and the CUSIP is 67424L100. A total of 44 filers reported holding OBALON THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $46,000 | -34.3% | 31,585 | -6.4% | 0.00% | – |
| Q4 2018 | $70,000 | +1.4% | 33,727 | +31.8% | 0.00% | – |
| Q3 2018 | $69,000 | +30.2% | 25,585 | +4.3% | 0.00% | – |
| Q2 2018 | $53,000 | -95.7% | 24,541 | -93.2% | 0.00% | – |
| Q1 2018 | $1,242,000 | -48.3% | 362,358 | -0.3% | 0.00% | – |
| Q4 2017 | $2,402,000 | -29.8% | 363,279 | +1.2% | 0.00% | – |
| Q3 2017 | $3,421,000 | -1.9% | 358,942 | +2.0% | 0.00% | – |
| Q2 2017 | $3,487,000 | +86.0% | 351,923 | +100.6% | 0.00% | – |
| Q1 2017 | $1,875,000 | – | 175,466 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|